Back to News
Market Impact: 0.22
Medtronic Invests In Pi-Cardia To Expand Complex TAVR Innovation
Source: Nasdaq
Healthcare & BiotechTechnology & InnovationCompany Fundamentals
Medtronic will make a strategic investment in Israel’s Pi-Cardia Ltd. to strengthen its structural heart portfolio and accelerate innovation for complex transcatheter aortic valve procedures. While deal size/terms weren’t provided, the move is broadly supportive for Medtronic’s cardiac expansion roadmap. Expected impact is likely limited near-term given no financial figures were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
MDT0.35
More News
- AI Capex, Gamble or Jackpot?: Market Snapshot
- ‘I told you so’: China’s chip sector is making breakthroughs—and U.S. export controls are the reasons why
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- The IPO drought is driving private equity-owned companies to the debt market to pay investors
- Hybe shares jump 10% as K-pop sensation BTS' tour lifts earnings hopes
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’